Influence of Donor and Recipient CYP3A4, CYP3A5 and ABCB1 Genotypes on Outcomes in Liver Transplants

被引：0
|
作者：
Debette-Gratien, M. [1 ]
Woillard, J. [2 ]
Picard, N. [2 ]
Sebbagh, M. [4 ]
Sautereau, D. [5 ]
Loustaud-Ratti, V. [1 ]
Samuel, D. [3 ]
Marquet, P. [2 ]
机构：
[1] Univ Limoges, CHU Limoges, INSERM, Hepatol,UMR 850, Limoges, France
[2] Univ Limoges, CHU Limoges, INSERM, Pharmacol & Toxicol,UMR 850, Limoges, France
[3] INSERM, Ctr Hepatobiliaire, Hepatol, Villejuif, France
[4] Ctr Hepatobiliaire, Hepatol, Villejuif, France
[5] CHU Limoges, Hepatol, Limoges, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D167
引用
收藏
页码：753 / 753
页数：1
相关论文
共 50 条
  • [1] Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients
    Debette-Gratien, Marilyne
    Woillard, Jean-Baptiste
    Picard, Nicolas
    Sebagh, Mylene
    Loustaud-Ratti, Veronique
    Sautereau, Denis
    Samuel, Didier
    Marquet, Pierre
    TRANSPLANTATION, 2016, 100 (10) : 2129 - 2137
  • [2] Impact of CYP3A5, CYP3A4, and ABCB1 Genotypes on Lung Transplant Recipient Early Clinical Outcomes
    Calabrese, D. R.
    Boettger, R.
    Dewey, K.
    Hui, C.
    Torgerson, D.
    Faust, H.
    Rajalingam, R.
    Hays, S.
    Singer, J.
    Shah, R.
    Leard, L.
    Kukreja, J.
    Golden, J.
    Greenland, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S151 - S151
  • [3] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Naushaed, Shaik Mohammad
    Payani, Addepalli
    Rupasree, Yedluri
    Hussain, Tajamul
    Alrokayan, Salman A.
    Kutala, Vijay Kumar
    PHARMACOLOGICAL REPORTS, 2019, 71 (03) : 385 - 392
  • [4] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Shaik Mohammad Naushad
    Addepalli Pavani
    Yedluri Rupasree
    Tajamul Hussain
    Salman A. Alrokayan
    Vijay Kumar Kutala
    Pharmacological Reports, 2019, 71 : 385 - 392
  • [5] IMPACT OF CYP3A5, CYP3A4, AND ABCB1 GENOTYPES ON TACROLIMUS DOSING AND MONITORING IN LIVER TRANSPLANT PATIENTS
    Ladd, Alexandra
    Pahim, Isabella Angeli
    Warren, Curtis
    Duarte, Sergio
    Zarrinpar, Ali
    HEPATOLOGY, 2022, 76 : S1284 - S1285
  • [6] IMPACT OF DONOR AND RECIPIENT CYP3A5, CYP3A4 AND ABCB1 POLYMORPHISMS ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME IN LIVER TRANSPLANT RECIPIENTS
    Falconer, Stuart
    Cryer, Claire
    Turner, David
    Oniscu, Gabriel
    TRANSPLANT INTERNATIONAL, 2013, 26 : 91 - 91
  • [7] Early clinical relevance of donor/recipient CYP3A5, CYP3A4 and ABCB1 polymorphisms after liver transplantation under tacrolimus immunosuppression
    Argudo-Ramirez, A.
    Gonzalez De Aledo, J. M.
    Ramirez, P.
    Castellote, J.
    Alia-Ramos, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S641 - S641
  • [8] INFLUENCE OF CYP3A4, CYP3A5, POR AND ABCB1 GENES ON TACROLIMUS RESPONSE IN LIVER TRANSPLANT RECIPIENTS
    Naldi, Graziella D'A. R.
    Pereira, Thales Dalessandro
    Fossaluza, Victor
    Nacif, Lucas
    Carneiro D'Albuquerque, Luiz Augusto
    Carrilho, Flair J.
    Ono, Suzane Kioko
    HEPATOLOGY, 2022, 76 : S1281 - S1282
  • [9] Effect of CYP3A5, CYP3A4, and ABCB1 Genotypes as Determinants of Tacrolimus Dose and Clinical Outcomes After Heart Transplantation
    Diaz-Molina, B.
    Tavira, B.
    Lambert, J. L.
    Bernardo, M. J.
    Alvarez, V.
    Coto, E.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2635 - 2638
  • [10] Influence of CYP3A4, CYP3A5, and ABCB1 genotype and expression on budesonide pharmacokinetics: A possible role of intestinal CYP3A4 expression
    Ufer, M.
    Dilger, K.
    Leschhorn, L.
    Daufresne, L. M.
    Mosyagin, I.
    Rosenstiel, P.
    Haesler, R.
    Kuehbacher, T.
    Nikolaus, S.
    Schreiber, S.
    Cascorbi, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (01) : 43 - 46
12345